Verona Pharma appoints Novartis Gene Therapies VP Lisa Deschamps to its board
March 2, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, verona, verona pharma
Verona Pharma has appointed Lisa Deschamps, Senior Vice President and Chief Business Officer of Novartis Gene Therapies, as Non-Executive Director …
SERB acquires BTG to expand its treatment portfolio for unmet medical needs
March 2, 2021Manufacturing and Production BTG, SERB, specialty pharmaceuticals
SERB Specialty Pharmaceuticals has purchased BTG Specialty Pharmaceuticals, a division of Boston Scientific that develops treatments with critical conditions, for …
Single Pfizer or AstraZeneca vaccine dose drastically reduces COVID-19 hospitalisations in over-80s
March 2, 2021Manufacturing and Production AstraZeneca, COVID-19, COVID-19 vaccine, Pfizer, Vaccine
A single dose of the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine reduces UK hospitalisations in over-80s by 80%, a Public Health …
Abivax appoints Dr Sophie Biguenet as Chief Medical Officer
March 2, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Clinical-stage biotechnology company Abivax has appointed Dr Sophie Biguenet as Chief Medical Officer. Dr Biguenet brings 25 years of experience …
Cancer Research UK joins forces with Teon to develop new cancer drug
March 2, 2021Manufacturing and Production Cancer, Cancer Research UK, Teon
Cancer Research UK and Teon Therapeutics have entered a collaboration agreement to progress the early phase clinical development of Teon’s new cancer drug. The partnership …
CN Bio receives UK government grant to develop single and multi-organ models for COVID-19 research
March 2, 2021Manufacturing and Production CN Bio, COVID-19
CN Bio, a leading developer of single and multi-organ microphysiological systems (MPS), has received a grant from innovation agency Innovate …
Iktos and Pfizer collaborate on AI drug design
March 2, 2021Manufacturing and Production AI, Iktos, Pfizer
Iktos has announced that its artificial intelligence (AI) technology for de novo design will be applied to selected Pfizer small-molecule …
Merck and Debiopharm agree €898m deal to develop head and neck cancer treatments
March 1, 2021Sales and Marketing Debiopharm, Merck, cancer treatment, head and neck cancer, xevinapant
German science and technology company Merck have agreed a worldwide in-licensing agreement with Debiopharm for the development and commercialisation of …
Oasmia acquires rights to cancer drug candidate Cantrixil in $44m deal
March 1, 2021Sales and Marketing Cancer, Kazia, Oasmia
Oasmia Pharmaceutical, an innovation-focused specialty pharmaceutical company, is set to acquire exclusive global development rights for Kazia Therapeutics’ ovarian cancer …
Evotec and Chinook to partner on new kidney disease treatments
March 1, 2021Sales and Marketing CKD, Chinook, Evotec, chronic kidney disease, kidney disease
Evotec and Chinook Therapeutics have agreed a deal to discover and develop new therapies for patients with chronic kidney diseases …
FDA approves Johnson & Johnson’s COVID-19 vaccine for emergency use
March 1, 2021Sales and Marketing COVID-19, Janssen, Johnson & Johnson, vaccines
The FDA has issued emergency use authorisation for Johnson & Johnson’s one-shot COVID-19 vaccine, approving the jab for use in …
Ipsen receives CHMP recommendation for Cabometyx in combination with Opdivo
March 1, 2021Sales and Marketing Cancer, EMA, ipsen
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for Ipsen’s Cabometyx (cabozantinib) in combination with …
MAPs during a global pandemic
February 26, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, MAPS
Early and managed access programmes provide opportunities for patients to get the treatments they need faster – but the COVID-19 …
Pharmafile.com’s top 10 news stories of the week
February 26, 2021Medical Communications news, pharma news, pharmaceuticals, pharmafile, top news stories
COVID-19 news has slowed down in the last week, allowing different pharma developments to take centre stage. In the last …
GSK’s Phase II otilimab study on COVID-19 patients promising for over-70s
February 26, 2021Medical Communications COVID-19, GSK, coronavirus, covid-19 treatment, otilimab
GlaxoSmithKline’s (GSK) Phase II OSCAR study of their otilimab antibody’s effect on COVID-19 patients has shown promising results in older …
How COVID-19 has changed pharmacovigilance
February 26, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, pharmacovigilance
The race to provide vaccines and treatments for coronavirus has seen a number of COVID-19 drugs reach the market in …
NICE recommends Novartis’ ribociclib in combination with fulvestrant for breast cancer
February 26, 2021Medical Communications Cancer, NICE, Novartis
NICE has recommended Novartis’ Kisqali (ribociclib) in combination with fulvestrant for women with prior endocrine therapy. It will be made …
MSD acquires Pandion Therapeutics in $1.85bn deal
February 26, 2021Medical Communications MSD, Pandion
MSD, known as Merck in the United States and Canada, has announced that it will acquire clinical-stage biotechnology company Pandion …
Takeda sells four diabetes products to Teijin Pharma for $1.25m
February 26, 2021Medical Communications Takeda
Takeda has entered into an agreement to transfer the assets, marketing rights, and, eventually, marketing authorisation associated with a portfolio …
Ghana is first African country to receive COVID-19 vaccines from COVAX
February 25, 2021The COVAX Facility have delivered their first batch of COVID-19 vaccines to Africa, with 600,000 doses of the Oxford-AstraZeneca vaccine …
